Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Molecular Modeling and Drug Design |
Description | Development, evaluation and optimization of drug discovery Site du laboratoire de Drug Design, |
Keywords | drug design, research, logiciels, Peptinov, Protein, Docking, Molecular visualization, Molecular modelling, Virtual screening, Cnam, Erc, Bioinformatics, Benchmarking |
WebSite | drugdesign.fr |
Host IP | 213.186.33.82 |
Location | France |
Euro€291,852
Dernière mise à jour: 2022-07-25 16:29:15
drugdesign.fr a un classement mondial Semrush de 36,266,097. drugdesign.fr a une valeur estimée à € 291,852, sur la base de ses revenus publicitaires estimés. drugdesign.fr reçoit environ 33,676 visiteurs uniques chaque jour. Son serveur Web est situé au France, avec l'adresse IP 213.186.33.82.Selon SiteAdvisor, drugdesign.fr est sûr à visiter. |
Valeur d'achat/vente | Euro€291,852 |
Revenus publicitaires quotidiens | Euro€270 |
Revenus publicitaires mensuels | Euro€8,083 |
Revenus publicitaires annuels | Euro€96,985 |
Visiteurs uniques quotidiens | 2,246 |
Remarque: Toutes les valeurs de trafic et de revenus sont des estimations. |
Host | Type | TTL | Data |
drugdesign.fr. | A | 3599 | IP: 213.186.33.82 |
drugdesign.fr. | NS | 3600 | NS Record: ns107.ovh.net. |
drugdesign.fr. | NS | 3600 | NS Record: dns107.ovh.net. |
drugdesign.fr. | MX | 3600 | MX Record: 1 mx4.mail.ovh.net. |
drugdesign.fr. | MX | 3600 | MX Record: 10 mx3.mail.ovh.net. |
drugdesign.fr. | TXT | 3600 | TXT Record: 1|www.drugdesign.fr |
Team News Publications Software and Data Contact Development, evaluation and optimization of drug discovery methods Hit/Lead/Drug discovery on different targets of therapeutic interest UDOCK, the protein docking entertainment system New approaches for teaching, research and a better integration of science into society VIDOCK (ERC-StG) New methods for the visualization and simulation of protein-protein interfaces Who We Are The M2D2 team is one of the three teams of the GBA Lab , CNAM , Paris. The M2D2 team is specialized in molecular modelling and its applications to drug discovery. We are currently pursuing different research projects in the lab covering widely this area of research. What We Do Drug Discovery Molecular Modelling Structural Bioinformatics Virtual Screening Protein Interaction Molecular Visualization News Links Laboratory GBA Peptinov Udock ViDOCK NRLiSt BDB ChemADE GRIV French Version © 2015 drugdesign.fr All rights reserved. | Design: HTML5 |
HTTP/1.1 200 OK date: Mon, 25 Jul 2022 08:22:49 GMT content-type: text/html server: Apache x-powered-by: PHP/5.4 accept-ranges: none vary: Accept-Encoding x-iplb-request-id: 416C4831:9E48_D5BA2152:0050_62DE52D9_5C64:28CCF x-iplb-instance: 27463 |
domain: drugdesign.fr status: ACTIVE hold: NO holder-c: ANO00-FRNIC admin-c: ANO00-FRNIC tech-c: OVH5-FRNIC zone-c: NFC1-FRNIC nsl-id: NSL45756-FRNIC registrar: OVH Expiry Date: 2022-12-02T11:46:58Z created: 2009-06-27T21:16:03Z last-update: 2021-12-02T12:35:58Z source: FRNIC ns-list: NSL45756-FRNIC nserver: dns107.ovh.net nserver: ns107.ovh.net source: FRNIC registrar: OVH type: Isp Option 1 address: 2 Rue Kellermann address: 59100 ROUBAIX country: FR phone: +33 8 99 70 17 61 fax-no: +33 3 20 20 09 58 e-mail: support@ovh.net website: http://www.ovh.com anonymous: NO registered: 1999-10-21T12:00:00Z source: FRNIC nic-hdl: ANO00-FRNIC type: PERSON contact: Ano Nymous registrar: OVH anonymous: YES obsoleted: NO eligstatus: not identified reachstatus: not identified source: FRNIC nic-hdl: ANO00-FRNIC type: PERSON contact: Ano Nymous registrar: OVH anonymous: YES obsoleted: NO eligstatus: not identified reachstatus: not identified source: FRNIC nic-hdl: OVH5-FRNIC type: ROLE contact: OVH NET address: OVH address: 140, quai du Sartel address: 59100 Roubaix country: FR phone: +33 8 99 70 17 61 e-mail: tech@ovh.net admin-c: OK217-FRNIC tech-c: OK217-FRNIC notify: tech@ovh.net registrar: OVH anonymous: NO obsoleted: NO eligstatus: not identified reachstatus: not identified source: FRNIC |